Efficacy of luteal supplementation of vaginal sildenafil and oral estrogen on pregnancy rate following IVF-ET in women with a history of thin endometria: A pilot study

In: Journal of Women's Medicine · 2010 · vol. 3(4) , pp. 155 · doi:10.5468/jwm.2010.3.4.155 · W2133958350
article OA: closed CC0 ⤵ 2 in-corpus citations
View on OpenAlex View at publisher
AI-generated summary by claude@2026-06, 2026-06-08

Concomitant administration of vaginal sildenafil and oral estrogen alongside progesterone luteal support increased clinical pregnancy rates two-fold in women with thin endometria undergoing IVF.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Objective: The several strategies for unexplained thin endometrium are under debate. We evaluated the effect of concomitant administration of vaginal sildenafil and oral estrogen in women with a thin endometrium undergoing in vitro fertilization (IVF). Methods: Forty-eight women showing thin endometrium less than 8 mm at the time of embryo transfer were randomly assigned to the study (n=21) and control group (n=27) in their subsequent IVF cycles. Routine luteal support was made by vaginal micronized progesterone 600 mg/day. In the study group, oral estradiol valerate 4 mg/day + vaginal sildenafil 25 mg/day was administered from the day of embryo transfer. Results: The clinical pregnancy rate was two-fold higher in the study group, although it was not statistically significant (47.6% vs. 25.9%, P=0.209). Conclusion: Our study supports that luteal administration of vaginal sildenafil and oral estrogen has modest beneficial impact on the uterine receptivity.

My notes (saved in your browser only)

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (3)

Cited by (2)

References (14)

Cited by (2)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK